Insight from Proactive analyst Ed Stacey on Mydecine Innovations Group, a biotech and life sciences company which is developing new therapies derived from psychedelics including psilocybin from mushrooms.
Proactive Analyst Ed Stacey looks at Mydecine Innovations
